• 0
EXCLUSIVE RETAILER

Respokare® NIOSH N95 Respirator Mask - 5000 Pack

$32,500.00

n95maskcompany

Revolutionary patented design by Innonix, a company at the forefront of cutting edge innovation in personal protective equipment for over 19 years. Advanced antiviral technology not only blocks 95% of small (.3 micron) particles, but inactivates up to 99.9% within minutes.

NIOSH APPROVED N95

Subjected to rigorous testing, this mask blocks 95% of very small (0.3 micron) particles. FDA Approved. CDC approval #84A-7796.

NELSON LABS TESTED

Validation tests were conducted in compliance with GLP regulation. Approved according to 42 CFR Part 84.

U.S. PATENTED ANTIVIRAL TECH

Revolutionary Innonix design decreases the transmission of one (or more than one) human pathogen by antibacterial, anti-fungal, and antiviral activity.

THE
TECHNOLOGY

Our patented multilayer, anti-viral technology has proven effective in the inactivation of 99.9% of flu viruses and other airborne health hazards.

WHAT DOES IT BLOCK?

Respokare® Anti-Viral Mask is highly effective against 18 common Seasonal & Pandemic Influenza Viruses, as well as a wide range of other pathogens, bacteria and fungi.

FIT
MATTERS

The
Numbers

The NIOSH approved N95 Respirator Facemask is made per industry standards. The ‘N95’ designation means that when the product is subjected to careful testing, it blocks at least 95% of very small (0.3 micron) test particles.

- NIOSH Approved N95 respirator Approval number 84A-7796

- Nelson Labs tested and approved according to 42 CFR Part 84

- Added patented anti-viral technology which inactivates 99.99% flu viruses

OnlyRespoKare®Anti-Viral NIOSHN95 Respirator does more than filtering –it “inactivates” pathogens.

- 99.99% virus and bacteria inactivation within 5 minutes.

- Tight-fitting to face as proven by various quantitative and qualitative fit tests.

- NIOSH approved Vertical seam and malleable aluminum nose bridge ensure a good seal

- Very soft and comfortable material on the inside

- High breathability and filtration achieved

Lab tests confirm: No Virus Detected.

As demonstrated in in-vitro laboratory testing on 5 minutes contact with the surface of the respirator, under test contact conditions. "Amount of Pathogens Killed" by the Respokare® NIOSH respirator calculated relative to the amount of microbes recovered from an inactive control mask resulted in a 95% confidence level.

All validation tests were conducted in compliance with Good Laboratory Practice (GLP) regulations and pursuant to International Standards by certified independent laboratories in the United States.

Respokare® Anti-Viral Mask is highly effective against 18 common Seasonal & Pandemic Influenza Viruses

In addition to influenza viruses, Respokare® inactivates a wide range of other pathogens, bacteria and fungi listed below: